Osteoporosis Disease Management Demonstration Project (0000-037)

Merck Sharp & Dohme LLC10,000 enrolled

Overview

The purpose of this study is to assess the impact of disease management interventions on bone mineral density (BMD) screening rates and osteoporosis treatment rates in women age 65 years or older.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

NONE

Enrollment

10,000

Conditions

Osteoporosis

Interventions

Disease Management AssessmentBEHAVIORAL

Eligibility

Sex: FEMALEMin age: 65 YearsMax age: 89 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Members of the Henry Ford Health System Exclusion Criteria: * Individuals who are not members of the Henry Ford Health System

Outcomes

Primary Outcomes

Bone mineral density (BMD) testing rates

Secondary Outcomes

Osteoporosis medication treatment rates

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.